Vericel to Expand Manufacturing, Move Headquarters to Burlington

Cambridge-based Vericel, a leader in advanced therapies for the sports medicine and severe burn care markets, has entered into a long-term lease agreement for a new state-of-the-art advanced cell therapy manufacturing and corporate headquarters facility at the Network Drive campus at Northwest Park in Burlington. The new facility, which will include approximately 125,000 square feet of manufacturing, laboratory and office space, will significantly increase the company’s cell therapy manufacturing capacity to support the long-term growth of its products. The new facility is expected to be completed in 2024, with commercial manufacturing expected to begin in 2025. (Source: Vericel Website, 02 February, 2022)